R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma

Published:2014 Issue:2 Volume:49 Page:107
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Lee Hong Ghi¹,Choi Yunsuk¹,Kim Sung-Yong¹,Kim Inho²,Kim Yeo-Kyeoung³,Kim Yang Soo⁴,Lee Ho Sup⁴,Kim Seok Jin⁵,Kim Jeong-A⁶,Park Byeong-Bae⁷,Park Jinny⁸,Shim Hyeok⁹,Eom Hyeon Seok¹⁰,Lee Junglim¹¹,Park Sung Kyu¹²,Cheong June-Won¹³,Park Keon Woo¹⁴

Affiliation:

1. Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.

2. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

3. Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea.

4. Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea.

5. Department of Medicine, Samsung Medical Center, Seoul, Korea.

6. Department of Internal Medicine, the Catholic University of Korea, Seoul, Korea.

7. Department of Internal Medicine, Hanyang University, Seoul, Korea.

8. Department of Internal Medicine, Gachon University, Incheon, Korea.

9. Department of Internal Medicine, Wonkwang University Hospital, Iksan, Korea.

10. Department of Internal Medicine, National Cancer Center, Ilsan, Korea.

11. Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea.

12. Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.

13. Department of Internal Medicine, Yonsei University, Seoul, Korea.

14. Department of Internal Medicine, Dankook University Hospital, Cheonan, Korea.

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://synapse.koreamed.org/pdf/10.5045/br.2014.49.2.107

Reference19 articles.

1. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

2. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

3. Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

4. Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis;Blood Research;2022-03-31

2. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis;BLOOD RES;2022

3. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy;International Journal of Molecular Sciences;2021-09-28

4. Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation;Annals of Transplantation;2021-09-13

5. Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores;Contrast Media & Molecular Imaging;2021-04-15